ViroSure
Private Company
Funding information not available
Overview
ViruSure is a specialized biosafety testing CRO serving global biopharma and advanced therapy clients from its Vienna, Austria base. Founded in 2010, the company offers a comprehensive suite of GLP/GMP-compliant services including virus clearance studies, in vitro/in vivo safety testing, cell and virus banking, and regulatory consultancy. Its business model is purely service-based, positioning it as a critical partner for companies developing biologics, vaccines, cell and gene therapies, and even cell-cultured meat, ensuring regulatory compliance and product safety.
Technology Platform
Integrated suite of GLP/GMP biosafety testing methodologies including virus clearance studies, in vitro/in vivo adventitious agent testing, molecular assays (PCR, NGS), cell & virus banking, and regulatory consultancy.
Opportunities
Risk Factors
Competitive Landscape
ViruSure competes in the specialized biosafety testing CRO market against large, full-service global CROs (e.g., LabCorp, Charles River Labs) and other niche players. Its differentiation is its deep focus on virus safety, expertise in advanced therapies, and strong European regulatory foundation, competing on quality and specialization rather than scale alone.